ARCHIVES

NCI Advisors Approve Plans To Continue Current Research Programs.

This article is from The Cancer Letter archive.

Vol. 34 No. 26 | July 3, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Neoadjuvant Surgery Makes Radiation Unnecessary In Some Early Breast Cancer

September 26, 2008

NCI Launches ALCHEMIST

September 5, 2014

Gene Vector Labs Seek Vector Producers

February 23, 1996

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

October 3, 2014

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991